While TET2 and DNMT3A mutations are two of most common genetic variations in CHIP and can precede myeloid malignancies, recent studies have also revealed associations between CHIP and other comorbid diseases [9,32]. The gene discussed is DNMT3A; the disease is myeloid neoplasm.